Jeffrey H. Chan

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Cardiac Substructure Dosimetry and Major Adverse Cardiac Events After Breast Radiation Therapy: A 12-Year Cohort Study With Normal Tissue Complication Probability Modeling.

Cardiac Substructure Dosimetry and Major Adverse Cardiac Events After Breast Radiation Therapy: A 12-Year Cohort Study With Normal Tissue Complication Probability Modeling.

Journal: International journal of radiation oncology, biology, physics

Published: January 12, 2026

Efficacy and safety of high-dose hypofractionated palliative radiotherapy (40 Gy in 10 daily fractions) for non-small cell lung cancer.

Efficacy and safety of high-dose hypofractionated palliative radiotherapy (40 Gy in 10 daily fractions) for non-small cell lung cancer.

Journal: Radiation oncology journal

Published: June 11, 2025

AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma.

AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma.

Journal: Military Medical Research

Published: October 29, 2024

Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.

Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.

Journal: JAMA network open

Published: July 17, 2023

The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.

The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.

Journal: JAMA network open

Published: November 05, 2021

Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy.

Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 24, 2021

Clinical application of circulating tumor DNA in breast cancer.

Clinical application of circulating tumor DNA in breast cancer.

Journal: Journal of cancer research and clinical oncology

Published: January 05, 2021

The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.

The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.

Journal: Cancer science

Published: November 04, 2020

Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: A dosimetric feasibility study.

Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: A dosimetric feasibility study.

Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists

Published: January 30, 2020

Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.

Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 10, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026